Publications by authors named "Michael Deinert"
Background: Treatment is indicated in dogs with preclinical degenerative mitral valve disease (DMVD) and cardiomegaly (stage B2). This is best diagnosed using echocardiography; however, relying upon this limits access to accurate diagnosis.
Objectives: To evaluate whether cardiac biomarker concentrations can be used alongside other clinical data to identify stage B2 dogs.
Article Synopsis
- The EPIC study monitored dogs with myxomatous mitral valve disease (MMVD) to observe how they develop congestive heart failure (CHF).
- It compared clinical and radiographic changes in dogs that developed CHF against those that did not, analyzing factors like heart rate and respiratory rate.
- Key findings showed that dogs approaching CHF had significant increases in respiratory rates and heart rates, along with decreases in body weight and temperature, highlighting respiratory rates as crucial indicators of CHF onset.